rss feeds Last update Researchers bring new insight into Chediak-Higashi syndrome, a devastating genetic disease, 15 minutes ago

Cancer news

Insights on how SHARPIN promotes cancer progression

Researchers at Sanford Burnham Prebys Medical Discovery (SBP) and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex ...

16 hours ago
popularity7 comments 0

Liver cancer: Lipid synthesis promotes tumor formation

Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the protein mTOR stimulates the ...

21 hours ago
popularity3 comments 0

Pushing the boundaries of melanoma border detection

Skin cancer experts will soon be able to benefit from a better way of spotting and identifying lesions, thanks to an improved image segmentation tool developed by computer scientists at Brunel University London.

21 hours ago
popularity4 comments 0

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD), ...

19 hours ago
popularity0 comments 0

PUMA pathway is a weak link in breast cancer metastasis

Substantial advancements have improved the success of chemotherapy, radiation, and surgical treatments for primary breast cancers. However, breast cancer that has spread, or metastasized, to other parts of the body remains ...

17 hours ago
popularity2 comments 0

Drinking and the risk of cancer

It's no secret that drinking alcohol is a risk factor for cancer. The National Cancer Institute says alcohol use is associated with a higher risk of developing cancers of the head and neck, esophagus, liver, breast, colon ...

Dec 11, 2017
popularity0 comments 0

Landmark CAR-T cancer study published

Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

Dec 10, 2017
popularity24 comments 0

More News Stories

Time of day affects severity of autoimmune disease

Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications. Understanding the effect of the interplay between ...

Sponsored account


Did you know? You can become a Medical Xpress sponsor and enjoy all our content without ads! Simply donate any amount and not only will you experience our site ad-free, but you will be part of the Science X community mission to promote science and technology knowledge.

More of today's stories

Find more news articles via sort by date page